Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:drug cross-reactivity'
(id=6821367 ; fe=en:drug cross-reactivity ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=6529 creation date=2017-06-25 touchdate=2025-10-08 08:42:50.000)
≈ 130 relations sortantes

  1. en:drug cross-reactivity -- r_associated #0: 43 / 1 -> en:smoke sensitivity
    n1=en:drug cross-reactivity | n2=en:smoke sensitivity | rel=r_associated | relid=0 | w=43
  2. en:drug cross-reactivity -- r_associated #0: 42 / 0.977 -> en:drug ineffective for unapproved indication
    n1=en:drug cross-reactivity | n2=en:drug ineffective for unapproved indication | rel=r_associated | relid=0 | w=42
  3. en:drug cross-reactivity -- r_associated #0: 40 / 0.93 -> en:adverse reaction to food
    n1=en:drug cross-reactivity | n2=en:adverse reaction to food | rel=r_associated | relid=0 | w=40
  4. en:drug cross-reactivity -- r_associated #0: 40 / 0.93 -> en:aspirin exacerbated respiratory disease
    n1=en:drug cross-reactivity | n2=en:aspirin exacerbated respiratory disease | rel=r_associated | relid=0 | w=40
  5. en:drug cross-reactivity -- r_associated #0: 40 / 0.93 -> en:reaction to colouring
    n1=en:drug cross-reactivity | n2=en:reaction to colouring | rel=r_associated | relid=0 | w=40
  6. en:drug cross-reactivity -- r_associated #0: 40 / 0.93 -> en:similar reaction on previous exposure to drug
    n1=en:drug cross-reactivity | n2=en:similar reaction on previous exposure to drug | rel=r_associated | relid=0 | w=40
  7. en:drug cross-reactivity -- r_associated #0: 37 / 0.86 -> en:toxic epidermal necrolysis
    n1=en:drug cross-reactivity | n2=en:toxic epidermal necrolysis | rel=r_associated | relid=0 | w=37
  8. en:drug cross-reactivity -- r_associated #0: 36 / 0.837 -> en:allergic colitis
    n1=en:drug cross-reactivity | n2=en:allergic colitis | rel=r_associated | relid=0 | w=36
  9. en:drug cross-reactivity -- r_associated #0: 35 / 0.814 -> en:allergy to fermented products
    n1=en:drug cross-reactivity | n2=en:allergy to fermented products | rel=r_associated | relid=0 | w=35
  10. en:drug cross-reactivity -- r_associated #0: 35 / 0.814 -> en:baboon syndrome due to drug
    n1=en:drug cross-reactivity | n2=en:baboon syndrome due to drug | rel=r_associated | relid=0 | w=35
  11. en:drug cross-reactivity -- r_associated #0: 35 / 0.814 -> en:drug action prolonged
    n1=en:drug cross-reactivity | n2=en:drug action prolonged | rel=r_associated | relid=0 | w=35
  12. en:drug cross-reactivity -- r_associated #0: 35 / 0.814 -> en:drug effect incomplete
    n1=en:drug cross-reactivity | n2=en:drug effect incomplete | rel=r_associated | relid=0 | w=35
  13. en:drug cross-reactivity -- r_associated #0: 35 / 0.814 -> en:enzyme induction
    n1=en:drug cross-reactivity | n2=en:enzyme induction | rel=r_associated | relid=0 | w=35
  14. en:drug cross-reactivity -- r_associated #0: 35 / 0.814 -> en:eosinophilic esophagitis
    n1=en:drug cross-reactivity | n2=en:eosinophilic esophagitis | rel=r_associated | relid=0 | w=35
  15. en:drug cross-reactivity -- r_associated #0: 35 / 0.814 -> en:erythroderma
    n1=en:drug cross-reactivity | n2=en:erythroderma | rel=r_associated | relid=0 | w=35
  16. en:drug cross-reactivity -- r_associated #0: 35 / 0.814 -> en:insulin sparing effect
    n1=en:drug cross-reactivity | n2=en:insulin sparing effect | rel=r_associated | relid=0 | w=35
  17. en:drug cross-reactivity -- r_associated #0: 35 / 0.814 -> en:no reaction on previous exposure to drug
    n1=en:drug cross-reactivity | n2=en:no reaction on previous exposure to drug | rel=r_associated | relid=0 | w=35
  18. en:drug cross-reactivity -- r_associated #0: 35 / 0.814 -> en:paradoxical drug reaction
    n1=en:drug cross-reactivity | n2=en:paradoxical drug reaction | rel=r_associated | relid=0 | w=35
  19. en:drug cross-reactivity -- r_associated #0: 35 / 0.814 -> en:positive cardiac inotropic effect
    n1=en:drug cross-reactivity | n2=en:positive cardiac inotropic effect | rel=r_associated | relid=0 | w=35
  20. en:drug cross-reactivity -- r_associated #0: 35 / 0.814 -> en:reaction to food additive
    n1=en:drug cross-reactivity | n2=en:reaction to food additive | rel=r_associated | relid=0 | w=35
  21. en:drug cross-reactivity -- r_associated #0: 35 / 0.814 -> en:rubber sensitivity
    n1=en:drug cross-reactivity | n2=en:rubber sensitivity | rel=r_associated | relid=0 | w=35
  22. en:drug cross-reactivity -- r_associated #0: 35 / 0.814 -> en:shortened therapeutic response
    n1=en:drug cross-reactivity | n2=en:shortened therapeutic response | rel=r_associated | relid=0 | w=35
  23. en:drug cross-reactivity -- r_associated #0: 35 / 0.814 -> en:solvent sensitivity
    n1=en:drug cross-reactivity | n2=en:solvent sensitivity | rel=r_associated | relid=0 | w=35
  24. en:drug cross-reactivity -- r_associated #0: 34 / 0.791 -> en:adverse event following immunization
    n1=en:drug cross-reactivity | n2=en:adverse event following immunization | rel=r_associated | relid=0 | w=34
  25. en:drug cross-reactivity -- r_associated #0: 34 / 0.791 -> en:adverse reaction
    n1=en:drug cross-reactivity | n2=en:adverse reaction | rel=r_associated | relid=0 | w=34
  26. en:drug cross-reactivity -- r_associated #0: 34 / 0.791 -> en:allergy to synthetic fabric
    n1=en:drug cross-reactivity | n2=en:allergy to synthetic fabric | rel=r_associated | relid=0 | w=34
  27. en:drug cross-reactivity -- r_associated #0: 34 / 0.791 -> en:contact stomatitis
    n1=en:drug cross-reactivity | n2=en:contact stomatitis | rel=r_associated | relid=0 | w=34
  28. en:drug cross-reactivity -- r_associated #0: 34 / 0.791 -> en:contrast media allergy
    n1=en:drug cross-reactivity | n2=en:contrast media allergy | rel=r_associated | relid=0 | w=34
  29. en:drug cross-reactivity -- r_associated #0: 34 / 0.791 -> en:effect, sympathomimetic
    n1=en:drug cross-reactivity | n2=en:effect, sympathomimetic | rel=r_associated | relid=0 | w=34
  30. en:drug cross-reactivity -- r_associated #0: 34 / 0.791 -> en:enzyme inhibition disorder
    n1=en:drug cross-reactivity | n2=en:enzyme inhibition disorder | rel=r_associated | relid=0 | w=34
  31. en:drug cross-reactivity -- r_associated #0: 34 / 0.791 -> en:flagellate dermatitis
    n1=en:drug cross-reactivity | n2=en:flagellate dermatitis | rel=r_associated | relid=0 | w=34
  32. en:drug cross-reactivity -- r_associated #0: 34 / 0.791 -> en:multidrug resistance process
    n1=en:drug cross-reactivity | n2=en:multidrug resistance process | rel=r_associated | relid=0 | w=34
  33. en:drug cross-reactivity -- r_associated #0: 34 / 0.791 -> en:negative cardiac inotropic effect
    n1=en:drug cross-reactivity | n2=en:negative cardiac inotropic effect | rel=r_associated | relid=0 | w=34
  34. en:drug cross-reactivity -- r_associated #0: 34 / 0.791 -> en:oral allergy syndrome
    n1=en:drug cross-reactivity | n2=en:oral allergy syndrome | rel=r_associated | relid=0 | w=34
  35. en:drug cross-reactivity -- r_associated #0: 34 / 0.791 -> en:reactogenicity event
    n1=en:drug cross-reactivity | n2=en:reactogenicity event | rel=r_associated | relid=0 | w=34
  36. en:drug cross-reactivity -- r_associated #0: 34 / 0.791 -> en:tachyphylaxis
    n1=en:drug cross-reactivity | n2=en:tachyphylaxis | rel=r_associated | relid=0 | w=34
  37. en:drug cross-reactivity -- r_associated #0: 34 / 0.791 -> en:treatment failure
    n1=en:drug cross-reactivity | n2=en:treatment failure | rel=r_associated | relid=0 | w=34
  38. en:drug cross-reactivity -- r_associated #0: 32 / 0.744 -> en:administration related reaction
    n1=en:drug cross-reactivity | n2=en:administration related reaction | rel=r_associated | relid=0 | w=32
  39. en:drug cross-reactivity -- r_associated #0: 32 / 0.744 -> en:drug allergy
    n1=en:drug cross-reactivity | n2=en:drug allergy | rel=r_associated | relid=0 | w=32
  40. en:drug cross-reactivity -- r_associated #0: 32 / 0.744 -> en:increased drug tolerance
    n1=en:drug cross-reactivity | n2=en:increased drug tolerance | rel=r_associated | relid=0 | w=32
  41. en:drug cross-reactivity -- r_associated #0: 32 / 0.744 -> en:remission not achieved
    n1=en:drug cross-reactivity | n2=en:remission not achieved | rel=r_associated | relid=0 | w=32
  42. en:drug cross-reactivity -- r_associated #0: 32 / 0.744 -> en:therapeutic and nontherapeutic responses
    n1=en:drug cross-reactivity | n2=en:therapeutic and nontherapeutic responses | rel=r_associated | relid=0 | w=32
  43. en:drug cross-reactivity -- r_associated #0: 32 / 0.744 -> en:therapy non-responder
    n1=en:drug cross-reactivity | n2=en:therapy non-responder | rel=r_associated | relid=0 | w=32
  44. en:drug cross-reactivity -- r_associated #0: 32 / 0.744 -> en:virologic failure
    n1=en:drug cross-reactivity | n2=en:virologic failure | rel=r_associated | relid=0 | w=32
  45. en:drug cross-reactivity -- r_associated #0: 31 / 0.721 -> en:chemical hypersensitivity
    n1=en:drug cross-reactivity | n2=en:chemical hypersensitivity | rel=r_associated | relid=0 | w=31
  46. en:drug cross-reactivity -- r_associated #0: 31 / 0.721 -> en:drug action decreased
    n1=en:drug cross-reactivity | n2=en:drug action decreased | rel=r_associated | relid=0 | w=31
  47. en:drug cross-reactivity -- r_associated #0: 31 / 0.721 -> en:drug hypersensitivity syndrome
    n1=en:drug cross-reactivity | n2=en:drug hypersensitivity syndrome | rel=r_associated | relid=0 | w=31
  48. en:drug cross-reactivity -- r_associated #0: 31 / 0.721 -> en:immediate post-injection reaction
    n1=en:drug cross-reactivity | n2=en:immediate post-injection reaction | rel=r_associated | relid=0 | w=31
  49. en:drug cross-reactivity -- r_associated #0: 31 / 0.721 -> en:reaction to azo-dyes
    n1=en:drug cross-reactivity | n2=en:reaction to azo-dyes | rel=r_associated | relid=0 | w=31
  50. en:drug cross-reactivity -- r_associated #0: 31 / 0.721 -> en:reaction to drug excipients
    n1=en:drug cross-reactivity | n2=en:reaction to drug excipients | rel=r_associated | relid=0 | w=31
  51. en:drug cross-reactivity -- r_associated #0: 31 / 0.721 -> en:surgical failure
    n1=en:drug cross-reactivity | n2=en:surgical failure | rel=r_associated | relid=0 | w=31
  52. en:drug cross-reactivity -- r_associated #0: 30 / 0.698 -> en:adverse event
    n1=en:drug cross-reactivity | n2=en:adverse event | rel=r_associated | relid=0 | w=30
  53. en:drug cross-reactivity -- r_associated #0: 30 / 0.698 -> en:dermal absorption increased
    n1=en:drug cross-reactivity | n2=en:dermal absorption increased | rel=r_associated | relid=0 | w=30
  54. en:drug cross-reactivity -- r_associated #0: 30 / 0.698 -> en:drug effect variable
    n1=en:drug cross-reactivity | n2=en:drug effect variable | rel=r_associated | relid=0 | w=30
  55. en:drug cross-reactivity -- r_associated #0: 30 / 0.698 -> en:drug skin rash
    n1=en:drug cross-reactivity | n2=en:drug skin rash | rel=r_associated | relid=0 | w=30
  56. en:drug cross-reactivity -- r_associated #0: 30 / 0.698 -> en:fishbane reaction
    n1=en:drug cross-reactivity | n2=en:fishbane reaction | rel=r_associated | relid=0 | w=30
  57. en:drug cross-reactivity -- r_associated #0: 30 / 0.698 -> en:perfume allergy
    n1=en:drug cross-reactivity | n2=en:perfume allergy | rel=r_associated | relid=0 | w=30
  58. en:drug cross-reactivity -- r_associated #0: 30 / 0.698 -> en:therapeutic product ineffective
    n1=en:drug cross-reactivity | n2=en:therapeutic product ineffective | rel=r_associated | relid=0 | w=30
  59. en:drug cross-reactivity -- r_associated #0: 30 / 0.698 -> en:therapeutic response unexpected
    n1=en:drug cross-reactivity | n2=en:therapeutic response unexpected | rel=r_associated | relid=0 | w=30
  60. en:drug cross-reactivity -- r_associated #0: 30 / 0.698 -> en:therapy partial responder
    n1=en:drug cross-reactivity | n2=en:therapy partial responder | rel=r_associated | relid=0 | w=30
  61. en:drug cross-reactivity -- r_associated #0: 29 / 0.674 -> en:contrast media reaction
    n1=en:drug cross-reactivity | n2=en:contrast media reaction | rel=r_associated | relid=0 | w=29
  62. en:drug cross-reactivity -- r_associated #0: 29 / 0.674 -> en:cross sensitivity reaction (lab test)
    n1=en:drug cross-reactivity | n2=en:cross sensitivity reaction (lab test) | rel=r_associated | relid=0 | w=29
  63. en:drug cross-reactivity -- r_associated #0: 29 / 0.674 -> en:dermal absorption impaired
    n1=en:drug cross-reactivity | n2=en:dermal absorption impaired | rel=r_associated | relid=0 | w=29
  64. en:drug cross-reactivity -- r_associated #0: 29 / 0.674 -> en:diet failure
    n1=en:drug cross-reactivity | n2=en:diet failure | rel=r_associated | relid=0 | w=29
  65. en:drug cross-reactivity -- r_associated #0: 29 / 0.674 -> en:drug action increased
    n1=en:drug cross-reactivity | n2=en:drug action increased | rel=r_associated | relid=0 | w=29
  66. en:drug cross-reactivity -- r_associated #0: 29 / 0.674 -> en:drug effect delayed
    n1=en:drug cross-reactivity | n2=en:drug effect delayed | rel=r_associated | relid=0 | w=29
  67. en:drug cross-reactivity -- r_associated #0: 29 / 0.674 -> en:drug resistance process
    n1=en:drug cross-reactivity | n2=en:drug resistance process | rel=r_associated | relid=0 | w=29
  68. en:drug cross-reactivity -- r_associated #0: 29 / 0.674 -> en:gluten sensitivity
    n1=en:drug cross-reactivity | n2=en:gluten sensitivity | rel=r_associated | relid=0 | w=29
  69. en:drug cross-reactivity -- r_associated #0: 29 / 0.674 -> en:increased therapeutic response
    n1=en:drug cross-reactivity | n2=en:increased therapeutic response | rel=r_associated | relid=0 | w=29
  70. en:drug cross-reactivity -- r_associated #0: 29 / 0.674 -> en:red man syndrome
    n1=en:drug cross-reactivity | n2=en:red man syndrome | rel=r_associated | relid=0 | w=29
  71. en:drug cross-reactivity -- r_associated #0: 29 / 0.674 -> en:therapeutic response changed
    n1=en:drug cross-reactivity | n2=en:therapeutic response changed | rel=r_associated | relid=0 | w=29
  72. en:drug cross-reactivity -- r_associated #0: 29 / 0.674 -> en:vaccine positive rechallenge
    n1=en:drug cross-reactivity | n2=en:vaccine positive rechallenge | rel=r_associated | relid=0 | w=29
  73. en:drug cross-reactivity -- r_associated #0: 28 / 0.651 -> en:decreased therapeutic response
    n1=en:drug cross-reactivity | n2=en:decreased therapeutic response | rel=r_associated | relid=0 | w=28
  74. en:drug cross-reactivity -- r_associated #0: 28 / 0.651 -> en:drug effect faster than expected
    n1=en:drug cross-reactivity | n2=en:drug effect faster than expected | rel=r_associated | relid=0 | w=28
  75. en:drug cross-reactivity -- r_associated #0: 28 / 0.651 -> en:drug tolerance
    n1=en:drug cross-reactivity | n2=en:drug tolerance | rel=r_associated | relid=0 | w=28
  76. en:drug cross-reactivity -- r_associated #0: 28 / 0.651 -> en:fixed drug eruption
    n1=en:drug cross-reactivity | n2=en:fixed drug eruption | rel=r_associated | relid=0 | w=28
  77. en:drug cross-reactivity -- r_associated #0: 28 / 0.651 -> en:flour sensitivity
    n1=en:drug cross-reactivity | n2=en:flour sensitivity | rel=r_associated | relid=0 | w=28
  78. en:drug cross-reactivity -- r_associated #0: 28 / 0.651 -> en:milk hypersensitivity
    n1=en:drug cross-reactivity | n2=en:milk hypersensitivity | rel=r_associated | relid=0 | w=28
  79. en:drug cross-reactivity -- r_associated #0: 28 / 0.651 -> en:reaction time decreased
    n1=en:drug cross-reactivity | n2=en:reaction time decreased | rel=r_associated | relid=0 | w=28
  80. en:drug cross-reactivity -- r_associated #0: 28 / 0.651 -> en:therapeutic response delayed
    n1=en:drug cross-reactivity | n2=en:therapeutic response delayed | rel=r_associated | relid=0 | w=28
  81. en:drug cross-reactivity -- r_associated #0: 28 / 0.651 -> en:toxicoderma
    n1=en:drug cross-reactivity | n2=en:toxicoderma | rel=r_associated | relid=0 | w=28
  82. en:drug cross-reactivity -- r_associated #0: 28 / 0.651 -> en:vaccines allergy
    n1=en:drug cross-reactivity | n2=en:vaccines allergy | rel=r_associated | relid=0 | w=28
  83. en:drug cross-reactivity -- r_associated #0: 27 / 0.628 -> effet indésirable d'un médicament
    n1=en:drug cross-reactivity | n2=effet indésirable d'un médicament | rel=r_associated | relid=0 | w=27
  84. en:drug cross-reactivity -- r_associated #0: 27 / 0.628 -> en:allergies to foods, food additives, drugs and other chemicals
    n1=en:drug cross-reactivity | n2=en:allergies to foods, food additives, drugs and other chemicals | rel=r_associated | relid=0 | w=27
  85. en:drug cross-reactivity -- r_associated #0: 27 / 0.628 -> en:allergy to caffeine
    n1=en:drug cross-reactivity | n2=en:allergy to caffeine | rel=r_associated | relid=0 | w=27
  86. en:drug cross-reactivity -- r_associated #0: 27 / 0.628 -> en:contact dermatitis
    n1=en:drug cross-reactivity | n2=en:contact dermatitis | rel=r_associated | relid=0 | w=27
  87. en:drug cross-reactivity -- r_associated #0: 27 / 0.628 -> en:decreased drug tolerance
    n1=en:drug cross-reactivity | n2=en:decreased drug tolerance | rel=r_associated | relid=0 | w=27
  88. en:drug cross-reactivity -- r_associated #0: 27 / 0.628 -> en:drug intolerance
    n1=en:drug cross-reactivity | n2=en:drug intolerance | rel=r_associated | relid=0 | w=27
  89. en:drug cross-reactivity -- r_associated #0: 27 / 0.628 -> en:no prior therapy
    n1=en:drug cross-reactivity | n2=en:no prior therapy | rel=r_associated | relid=0 | w=27
  90. en:drug cross-reactivity -- r_associated #0: 27 / 0.628 -> en:renin-angiotensin system inhibition
    n1=en:drug cross-reactivity | n2=en:renin-angiotensin system inhibition | rel=r_associated | relid=0 | w=27
  91. en:drug cross-reactivity -- r_associated #0: 27 / 0.628 -> en:therapy responder
    n1=en:drug cross-reactivity | n2=en:therapy responder | rel=r_associated | relid=0 | w=27
  92. en:drug cross-reactivity -- r_associated #0: 26 / 0.605 -> en:adverse reaction to drug
    n1=en:drug cross-reactivity | n2=en:adverse reaction to drug | rel=r_associated | relid=0 | w=26
  93. en:drug cross-reactivity -- r_associated #0: 26 / 0.605 -> en:allergic gastroenteritis
    n1=en:drug cross-reactivity | n2=en:allergic gastroenteritis | rel=r_associated | relid=0 | w=26
  94. en:drug cross-reactivity -- r_associated #0: 26 / 0.605 -> en:drug ineffective
    n1=en:drug cross-reactivity | n2=en:drug ineffective | rel=r_associated | relid=0 | w=26
  95. en:drug cross-reactivity -- r_associated #0: 26 / 0.605 -> en:food allergy
    n1=en:drug cross-reactivity | n2=en:food allergy | rel=r_associated | relid=0 | w=26
  96. en:drug cross-reactivity -- r_associated #0: 26 / 0.605 -> en:idiosyncratic drug effect
    n1=en:drug cross-reactivity | n2=en:idiosyncratic drug effect | rel=r_associated | relid=0 | w=26
  97. en:drug cross-reactivity -- r_associated #0: 26 / 0.605 -> en:infusion-related reaction
    n1=en:drug cross-reactivity | n2=en:infusion-related reaction | rel=r_associated | relid=0 | w=26
  98. en:drug cross-reactivity -- r_associated #0: 26 / 0.605 -> en:iodine allergy
    n1=en:drug cross-reactivity | n2=en:iodine allergy | rel=r_associated | relid=0 | w=26
  99. en:drug cross-reactivity -- r_associated #0: 26 / 0.605 -> en:prolonged therapeutic response
    n1=en:drug cross-reactivity | n2=en:prolonged therapeutic response | rel=r_associated | relid=0 | w=26
  100. en:drug cross-reactivity -- r_associated #0: 26 / 0.605 -> en:reaction to preservatives
    n1=en:drug cross-reactivity | n2=en:reaction to preservatives | rel=r_associated | relid=0 | w=26
  101. en:drug cross-reactivity -- r_associated #0: 26 / 0.605 -> en:therapeutic product ineffective for unapproved indication
    n1=en:drug cross-reactivity | n2=en:therapeutic product ineffective for unapproved indication | rel=r_associated | relid=0 | w=26
  102. en:drug cross-reactivity -- r_associated #0: 26 / 0.605 -> en:transplantation associated food allergy
    n1=en:drug cross-reactivity | n2=en:transplantation associated food allergy | rel=r_associated | relid=0 | w=26
  103. en:drug cross-reactivity -- r_associated #0: 25 / 0.581 -> en:drug
    n1=en:drug cross-reactivity | n2=en:drug | rel=r_associated | relid=0 | w=25
  104. en:drug cross-reactivity -- r_associated #0: 21 / 0.488 -> réaction indésirable
    n1=en:drug cross-reactivity | n2=réaction indésirable | rel=r_associated | relid=0 | w=21
  105. en:drug cross-reactivity -- r_associated #0: 20 / 0.465 -> allergie à un médicament
    n1=en:drug cross-reactivity | n2=allergie à un médicament | rel=r_associated | relid=0 | w=20
  106. en:drug cross-reactivity -- r_associated #0: 20 / 0.465 -> allergie alimentaire
    n1=en:drug cross-reactivity | n2=allergie alimentaire | rel=r_associated | relid=0 | w=20
  107. en:drug cross-reactivity -- r_associated #0: 20 / 0.465 -> Allergie alimentaire
    n1=en:drug cross-reactivity | n2=Allergie alimentaire | rel=r_associated | relid=0 | w=20
  108. en:drug cross-reactivity -- r_associated #0: 20 / 0.465 -> allergie aux médicaments
    n1=en:drug cross-reactivity | n2=allergie aux médicaments | rel=r_associated | relid=0 | w=20
  109. en:drug cross-reactivity -- r_associated #0: 20 / 0.465 -> allergie médicamenteuse
    n1=en:drug cross-reactivity | n2=allergie médicamenteuse | rel=r_associated | relid=0 | w=20
  110. en:drug cross-reactivity -- r_associated #0: 20 / 0.465 -> en:cutaneous adverse drug reaction
    n1=en:drug cross-reactivity | n2=en:cutaneous adverse drug reaction | rel=r_associated | relid=0 | w=20
  111. en:drug cross-reactivity -- r_associated #0: 20 / 0.465 -> en:erythrodermatitis
    n1=en:drug cross-reactivity | n2=en:erythrodermatitis | rel=r_associated | relid=0 | w=20
  112. en:drug cross-reactivity -- r_associated #0: 20 / 0.465 -> en:gastrointestinal allergy
    n1=en:drug cross-reactivity | n2=en:gastrointestinal allergy | rel=r_associated | relid=0 | w=20
  113. en:drug cross-reactivity -- r_associated #0: 20 / 0.465 -> en:generalized exfoliative dermatitis
    n1=en:drug cross-reactivity | n2=en:generalized exfoliative dermatitis | rel=r_associated | relid=0 | w=20
  114. en:drug cross-reactivity -- r_associated #0: 20 / 0.465 -> en:Lyell's disease
    n1=en:drug cross-reactivity | n2=en:Lyell's disease | rel=r_associated | relid=0 | w=20
  115. en:drug cross-reactivity -- r_associated #0: 20 / 0.465 -> en:Lyell's syndrome
    n1=en:drug cross-reactivity | n2=en:Lyell's syndrome | rel=r_associated | relid=0 | w=20
  116. en:drug cross-reactivity -- r_associated #0: 20 / 0.465 -> en:pigmented drug induced erythema
    n1=en:drug cross-reactivity | n2=en:pigmented drug induced erythema | rel=r_associated | relid=0 | w=20
  117. en:drug cross-reactivity -- r_associated #0: 20 / 0.465 -> en:side effects of drug
    n1=en:drug cross-reactivity | n2=en:side effects of drug | rel=r_associated | relid=0 | w=20
  118. en:drug cross-reactivity -- r_associated #0: 20 / 0.465 -> en:toxidermia
    n1=en:drug cross-reactivity | n2=en:toxidermia | rel=r_associated | relid=0 | w=20
  119. en:drug cross-reactivity -- r_associated #0: 20 / 0.465 -> en:toxidermitis
    n1=en:drug cross-reactivity | n2=en:toxidermitis | rel=r_associated | relid=0 | w=20
  120. en:drug cross-reactivity -- r_associated #0: 20 / 0.465 -> érythème pigmenté fixe
    n1=en:drug cross-reactivity | n2=érythème pigmenté fixe | rel=r_associated | relid=0 | w=20
  121. en:drug cross-reactivity -- r_associated #0: 20 / 0.465 -> érythrodermie
    n1=en:drug cross-reactivity | n2=érythrodermie | rel=r_associated | relid=0 | w=20
  122. en:drug cross-reactivity -- r_associated #0: 20 / 0.465 -> érythrodermie bulleuse avec épidermolyse
    n1=en:drug cross-reactivity | n2=érythrodermie bulleuse avec épidermolyse | rel=r_associated | relid=0 | w=20
  123. en:drug cross-reactivity -- r_associated #0: 20 / 0.465 -> évènement indésirable
    n1=en:drug cross-reactivity | n2=évènement indésirable | rel=r_associated | relid=0 | w=20
  124. en:drug cross-reactivity -- r_associated #0: 20 / 0.465 -> événement indésirable
    n1=en:drug cross-reactivity | n2=événement indésirable | rel=r_associated | relid=0 | w=20
  125. en:drug cross-reactivity -- r_associated #0: 20 / 0.465 -> incident indésirable
    n1=en:drug cross-reactivity | n2=incident indésirable | rel=r_associated | relid=0 | w=20
  126. en:drug cross-reactivity -- r_associated #0: 20 / 0.465 -> oesophagite à éosinophiles
    n1=en:drug cross-reactivity | n2=oesophagite à éosinophiles | rel=r_associated | relid=0 | w=20
  127. en:drug cross-reactivity -- r_associated #0: 20 / 0.465 -> réaction à la coloration
    n1=en:drug cross-reactivity | n2=réaction à la coloration | rel=r_associated | relid=0 | w=20
  128. en:drug cross-reactivity -- r_associated #0: 20 / 0.465 -> tachyphylaxie
    n1=en:drug cross-reactivity | n2=tachyphylaxie | rel=r_associated | relid=0 | w=20
  129. en:drug cross-reactivity -- r_associated #0: 20 / 0.465 -> tachyphylaxies
    n1=en:drug cross-reactivity | n2=tachyphylaxies | rel=r_associated | relid=0 | w=20
  130. en:drug cross-reactivity -- r_associated #0: 20 / 0.465 -> toxidermie
    n1=en:drug cross-reactivity | n2=toxidermie | rel=r_associated | relid=0 | w=20
≈ 159 relations entrantes

  1. en:adverse reaction to drug --- r_associated #0: 461 --> en:drug cross-reactivity
    n1=en:adverse reaction to drug | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=461
  2. effet indésirable d'un médicament --- r_associated #0: 457 --> en:drug cross-reactivity
    n1=effet indésirable d'un médicament | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=457
  3. tachyphylaxie --- r_associated #0: 136 --> en:drug cross-reactivity
    n1=tachyphylaxie | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=136
  4. tachyphylaxies --- r_associated #0: 133 --> en:drug cross-reactivity
    n1=tachyphylaxies | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=133
  5. en:tachyphylaxis --- r_associated #0: 127 --> en:drug cross-reactivity
    n1=en:tachyphylaxis | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=127
  6. allergie alimentaire --- r_associated #0: 120 --> en:drug cross-reactivity
    n1=allergie alimentaire | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=120
  7. en:food allergy --- r_associated #0: 118 --> en:drug cross-reactivity
    n1=en:food allergy | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=118
  8. allergie aux médicaments --- r_associated #0: 110 --> en:drug cross-reactivity
    n1=allergie aux médicaments | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=110
  9. en:drug allergy --- r_associated #0: 110 --> en:drug cross-reactivity
    n1=en:drug allergy | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=110
  10. allergie médicamenteuse --- r_associated #0: 107 --> en:drug cross-reactivity
    n1=allergie médicamenteuse | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=107
  11. allergie à un médicament --- r_associated #0: 105 --> en:drug cross-reactivity
    n1=allergie à un médicament | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=105
  12. oesophagite à éosinophiles --- r_associated #0: 76 --> en:drug cross-reactivity
    n1=oesophagite à éosinophiles | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=76
  13. œsophagite à éosinophiles --- r_associated #0: 75 --> en:drug cross-reactivity
    n1=œsophagite à éosinophiles | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=75
  14. en:gastrointestinal allergy --- r_associated #0: 70 --> en:drug cross-reactivity
    n1=en:gastrointestinal allergy | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=70
  15. œsophagite à éosinophiles --- r_associated #0: 70 --> en:drug cross-reactivity
    n1=œsophagite à éosinophiles | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=70
  16. érythrodermie bulleuse avec épidermolyse --- r_associated #0: 60 --> en:drug cross-reactivity
    n1=érythrodermie bulleuse avec épidermolyse | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=60
  17. en:toxic epidermal necrolysis --- r_associated #0: 57 --> en:drug cross-reactivity
    n1=en:toxic epidermal necrolysis | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=57
  18. réaction à la coloration --- r_associated #0: 53 --> en:drug cross-reactivity
    n1=réaction à la coloration | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=53
  19. en:fixed drug eruption --- r_associated #0: 51 --> en:drug cross-reactivity
    n1=en:fixed drug eruption | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=51
  20. érythème pigmenté fixe --- r_associated #0: 51 --> en:drug cross-reactivity
    n1=érythème pigmenté fixe | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=51
  21. en:Lyell's syndrome --- r_associated #0: 50 --> en:drug cross-reactivity
    n1=en:Lyell's syndrome | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=50
  22. en:pigmented drug induced erythema --- r_associated #0: 50 --> en:drug cross-reactivity
    n1=en:pigmented drug induced erythema | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=50
  23. en:reaction to colouring --- r_associated #0: 50 --> en:drug cross-reactivity
    n1=en:reaction to colouring | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=50
  24. en:eosinophilic esophagitis --- r_associated #0: 47 --> en:drug cross-reactivity
    n1=en:eosinophilic esophagitis | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=47
  25. érythrodermie --- r_associated #0: 45 --> en:drug cross-reactivity
    n1=érythrodermie | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=45
  26. en:erythroderma --- r_associated #0: 44 --> en:drug cross-reactivity
    n1=en:erythroderma | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=44
  27. événement indésirable --- r_associated #0: 44 --> en:drug cross-reactivity
    n1=événement indésirable | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=44
  28. en:therapeutic product ineffective --- r_associated #0: 43 --> en:drug cross-reactivity
    n1=en:therapeutic product ineffective | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=43
  29. en:drug tolerance --- r_associated #0: 42 --> en:drug cross-reactivity
    n1=en:drug tolerance | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=42
  30. en:adverse event --- r_associated #0: 40 --> en:drug cross-reactivity
    n1=en:adverse event | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=40
  31. en:no reaction on previous exposure to drug --- r_associated #0: 40 --> en:drug cross-reactivity
    n1=en:no reaction on previous exposure to drug | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=40
  32. incident indésirable --- r_associated #0: 40 --> en:drug cross-reactivity
    n1=incident indésirable | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=40
  33. en:drug intolerance --- r_associated #0: 39 --> en:drug cross-reactivity
    n1=en:drug intolerance | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=39
  34. en:no prior therapy --- r_associated #0: 37 --> en:drug cross-reactivity
    n1=en:no prior therapy | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=37
  35. en:gluten sensitivity --- r_associated #0: 36 --> en:drug cross-reactivity
    n1=en:gluten sensitivity | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=36
  36. en:adverse event following immunization --- r_associated #0: 35 --> en:drug cross-reactivity
    n1=en:adverse event following immunization | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=35
  37. en:allergic gastroenteritis --- r_associated #0: 35 --> en:drug cross-reactivity
    n1=en:allergic gastroenteritis | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=35
  38. en:allergy to synthetic fabric --- r_associated #0: 35 --> en:drug cross-reactivity
    n1=en:allergy to synthetic fabric | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=35
  39. en:contact stomatitis --- r_associated #0: 35 --> en:drug cross-reactivity
    n1=en:contact stomatitis | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=35
  40. en:diet failure --- r_associated #0: 35 --> en:drug cross-reactivity
    n1=en:diet failure | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=35
  41. en:drug action increased --- r_associated #0: 35 --> en:drug cross-reactivity
    n1=en:drug action increased | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=35
  42. en:drug effect variable --- r_associated #0: 35 --> en:drug cross-reactivity
    n1=en:drug effect variable | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=35
  43. en:negative cardiac inotropic effect --- r_associated #0: 35 --> en:drug cross-reactivity
    n1=en:negative cardiac inotropic effect | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=35
  44. en:rubber sensitivity --- r_associated #0: 35 --> en:drug cross-reactivity
    n1=en:rubber sensitivity | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=35
  45. en:therapeutic response delayed --- r_associated #0: 35 --> en:drug cross-reactivity
    n1=en:therapeutic response delayed | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=35
  46. en:therapy partial responder --- r_associated #0: 35 --> en:drug cross-reactivity
    n1=en:therapy partial responder | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=35
  47. en:toxidermitis --- r_associated #0: 35 --> en:drug cross-reactivity
    n1=en:toxidermitis | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=35
  48. en:aspirin exacerbated respiratory disease --- r_associated #0: 34 --> en:drug cross-reactivity
    n1=en:aspirin exacerbated respiratory disease | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=34
  49. en:dermal absorption increased --- r_associated #0: 34 --> en:drug cross-reactivity
    n1=en:dermal absorption increased | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=34
  50. en:positive cardiac inotropic effect --- r_associated #0: 34 --> en:drug cross-reactivity
    n1=en:positive cardiac inotropic effect | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=34
  51. Allergie alimentaire --- r_associated #0: 33 --> en:drug cross-reactivity
    n1=Allergie alimentaire | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=33
  52. en:side effects of drug --- r_associated #0: 33 --> en:drug cross-reactivity
    n1=en:side effects of drug | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=33
  53. en:contrast media reaction --- r_associated #0: 32 --> en:drug cross-reactivity
    n1=en:contrast media reaction | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=32
  54. en:drug action prolonged --- r_associated #0: 32 --> en:drug cross-reactivity
    n1=en:drug action prolonged | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=32
  55. en:drug effect faster than expected --- r_associated #0: 32 --> en:drug cross-reactivity
    n1=en:drug effect faster than expected | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=32
  56. en:flagellate dermatitis --- r_associated #0: 32 --> en:drug cross-reactivity
    n1=en:flagellate dermatitis | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=32
  57. en:shortened therapeutic response --- r_associated #0: 32 --> en:drug cross-reactivity
    n1=en:shortened therapeutic response | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=32
  58. en:similar reaction on previous exposure to drug --- r_associated #0: 32 --> en:drug cross-reactivity
    n1=en:similar reaction on previous exposure to drug | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=32
  59. en:toxidermia --- r_associated #0: 32 --> en:drug cross-reactivity
    n1=en:toxidermia | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=32
  60. en:transplantation associated food allergy --- r_associated #0: 32 --> en:drug cross-reactivity
    n1=en:transplantation associated food allergy | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=32
  61. en:treatment failure --- r_associated #0: 32 --> en:drug cross-reactivity
    n1=en:treatment failure | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=32
  62. en:administration related reaction --- r_associated #0: 31 --> en:drug cross-reactivity
    n1=en:administration related reaction | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=31
  63. en:idiosyncratic drug effect --- r_associated #0: 31 --> en:drug cross-reactivity
    n1=en:idiosyncratic drug effect | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=31
  64. en:infusion-related reaction --- r_associated #0: 31 --> en:drug cross-reactivity
    n1=en:infusion-related reaction | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=31
  65. en:insulin sparing effect --- r_associated #0: 31 --> en:drug cross-reactivity
    n1=en:insulin sparing effect | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=31
  66. en:toxicoderma --- r_associated #0: 31 --> en:drug cross-reactivity
    n1=en:toxicoderma | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=31
  67. toxidermie --- r_associated #0: 31 --> en:drug cross-reactivity
    n1=toxidermie | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=31
  68. Érythrodermie bulleuse avec épidermolyse --- r_associated #0: 31 --> en:drug cross-reactivity
    n1=Érythrodermie bulleuse avec épidermolyse | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=31
  69. en:adverse reaction --- r_associated #0: 30 --> en:drug cross-reactivity
    n1=en:adverse reaction | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=30
  70. en:adverse reaction to food --- r_associated #0: 30 --> en:drug cross-reactivity
    n1=en:adverse reaction to food | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=30
  71. en:allergies to foods, food additives, drugs and other chemicals --- r_associated #0: 30 --> en:drug cross-reactivity
    n1=en:allergies to foods, food additives, drugs and other chemicals | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=30
  72. en:contrast media allergy --- r_associated #0: 30 --> en:drug cross-reactivity
    n1=en:contrast media allergy | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=30
  73. en:decreased drug tolerance --- r_associated #0: 30 --> en:drug cross-reactivity
    n1=en:decreased drug tolerance | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=30
  74. en:drug action decreased --- r_associated #0: 30 --> en:drug cross-reactivity
    n1=en:drug action decreased | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=30
  75. en:drug effect delayed --- r_associated #0: 30 --> en:drug cross-reactivity
    n1=en:drug effect delayed | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=30
  76. en:erythrodermatitis --- r_associated #0: 30 --> en:drug cross-reactivity
    n1=en:erythrodermatitis | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=30
  77. en:flour sensitivity --- r_associated #0: 30 --> en:drug cross-reactivity
    n1=en:flour sensitivity | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=30
  78. en:generalized exfoliative dermatitis --- r_associated #0: 30 --> en:drug cross-reactivity
    n1=en:generalized exfoliative dermatitis | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=30
  79. en:increased drug tolerance --- r_associated #0: 30 --> en:drug cross-reactivity
    n1=en:increased drug tolerance | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=30
  80. en:renin-angiotensin system inhibition --- r_associated #0: 30 --> en:drug cross-reactivity
    n1=en:renin-angiotensin system inhibition | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=30
  81. réaction indésirable --- r_associated #0: 30 --> en:drug cross-reactivity
    n1=réaction indésirable | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=30
  82. en:allergic colitis --- r_associated #0: 29 --> en:drug cross-reactivity
    n1=en:allergic colitis | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=29
  83. en:cross sensitivity reaction (lab test) --- r_associated #0: 29 --> en:drug cross-reactivity
    n1=en:cross sensitivity reaction (lab test) | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=29
  84. en:immediate post-injection reaction --- r_associated #0: 29 --> en:drug cross-reactivity
    n1=en:immediate post-injection reaction | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=29
  85. en:increased therapeutic response --- r_associated #0: 29 --> en:drug cross-reactivity
    n1=en:increased therapeutic response | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=29
  86. en:milk hypersensitivity --- r_associated #0: 29 --> en:drug cross-reactivity
    n1=en:milk hypersensitivity | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=29
  87. en:paradoxical drug reaction --- r_associated #0: 29 --> en:drug cross-reactivity
    n1=en:paradoxical drug reaction | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=29
  88. en:prolonged therapeutic response --- r_associated #0: 29 --> en:drug cross-reactivity
    n1=en:prolonged therapeutic response | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=29
  89. en:reaction time decreased --- r_associated #0: 29 --> en:drug cross-reactivity
    n1=en:reaction time decreased | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=29
  90. en:reaction to preservatives --- r_associated #0: 29 --> en:drug cross-reactivity
    n1=en:reaction to preservatives | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=29
  91. en:therapeutic response changed --- r_associated #0: 29 --> en:drug cross-reactivity
    n1=en:therapeutic response changed | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=29
  92. en:therapeutic response unexpected --- r_associated #0: 29 --> en:drug cross-reactivity
    n1=en:therapeutic response unexpected | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=29
  93. en:toxicodermia --- r_associated #0: 29 --> en:drug cross-reactivity
    n1=en:toxicodermia | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=29
  94. en:vaccine positive rechallenge --- r_associated #0: 29 --> en:drug cross-reactivity
    n1=en:vaccine positive rechallenge | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=29
  95. en:Lyell's disease --- r_associated #0: 28 --> en:drug cross-reactivity
    n1=en:Lyell's disease | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=28
  96. en:chemical hypersensitivity --- r_associated #0: 28 --> en:drug cross-reactivity
    n1=en:chemical hypersensitivity | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=28
  97. en:cutaneous adverse drug reaction --- r_associated #0: 28 --> en:drug cross-reactivity
    n1=en:cutaneous adverse drug reaction | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=28
  98. en:decreased therapeutic response --- r_associated #0: 28 --> en:drug cross-reactivity
    n1=en:decreased therapeutic response | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=28
  99. en:drug effect incomplete --- r_associated #0: 28 --> en:drug cross-reactivity
    n1=en:drug effect incomplete | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=28
  100. en:drug resistance process --- r_associated #0: 28 --> en:drug cross-reactivity
    n1=en:drug resistance process | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=28
  101. en:effect, sympathomimetic --- r_associated #0: 28 --> en:drug cross-reactivity
    n1=en:effect, sympathomimetic | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=28
  102. en:enzyme inhibition disorder --- r_associated #0: 28 --> en:drug cross-reactivity
    n1=en:enzyme inhibition disorder | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=28
  103. en:fishbane reaction --- r_associated #0: 28 --> en:drug cross-reactivity
    n1=en:fishbane reaction | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=28
  104. en:reactogenicity event --- r_associated #0: 28 --> en:drug cross-reactivity
    n1=en:reactogenicity event | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=28
  105. en:therapeutic product ineffective for unapproved indication --- r_associated #0: 28 --> en:drug cross-reactivity
    n1=en:therapeutic product ineffective for unapproved indication | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=28
  106. en:therapy non-responder --- r_associated #0: 28 --> en:drug cross-reactivity
    n1=en:therapy non-responder | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=28
  107. en:contact dermatitis --- r_associated #0: 27 --> en:drug cross-reactivity
    n1=en:contact dermatitis | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=27
  108. en:dermal absorption impaired --- r_associated #0: 27 --> en:drug cross-reactivity
    n1=en:dermal absorption impaired | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=27
  109. en:drug skin rash --- r_associated #0: 27 --> en:drug cross-reactivity
    n1=en:drug skin rash | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=27
  110. en:multidrug resistance process --- r_associated #0: 27 --> en:drug cross-reactivity
    n1=en:multidrug resistance process | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=27
  111. en:perfume allergy --- r_associated #0: 27 --> en:drug cross-reactivity
    n1=en:perfume allergy | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=27
  112. en:reaction to azo-dyes --- r_associated #0: 27 --> en:drug cross-reactivity
    n1=en:reaction to azo-dyes | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=27
  113. en:remission not achieved --- r_associated #0: 27 --> en:drug cross-reactivity
    n1=en:remission not achieved | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=27
  114. en:surgical failure --- r_associated #0: 27 --> en:drug cross-reactivity
    n1=en:surgical failure | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=27
  115. en:toxicodermitis --- r_associated #0: 27 --> en:drug cross-reactivity
    n1=en:toxicodermitis | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=27
  116. évènement indésirable --- r_associated #0: 27 --> en:drug cross-reactivity
    n1=évènement indésirable | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=27
  117. en:baboon syndrome due to drug --- r_associated #0: 26 --> en:drug cross-reactivity
    n1=en:baboon syndrome due to drug | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=26
  118. en:drug hypersensitivity syndrome --- r_associated #0: 26 --> en:drug cross-reactivity
    n1=en:drug hypersensitivity syndrome | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=26
  119. en:drug ineffective --- r_associated #0: 26 --> en:drug cross-reactivity
    n1=en:drug ineffective | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=26
  120. en:drug ineffective for unapproved indication --- r_associated #0: 26 --> en:drug cross-reactivity
    n1=en:drug ineffective for unapproved indication | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=26
  121. en:iodine allergy --- r_associated #0: 26 --> en:drug cross-reactivity
    n1=en:iodine allergy | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=26
  122. en:therapeutic and nontherapeutic responses --- r_associated #0: 26 --> en:drug cross-reactivity
    n1=en:therapeutic and nontherapeutic responses | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=26
  123. en:therapy responder --- r_associated #0: 26 --> en:drug cross-reactivity
    n1=en:therapy responder | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=26
  124. en:toxicodermatosis --- r_associated #0: 26 --> en:drug cross-reactivity
    n1=en:toxicodermatosis | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=26
  125. en:vaccines allergy --- r_associated #0: 26 --> en:drug cross-reactivity
    n1=en:vaccines allergy | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=26
  126. en:allergy to caffeine --- r_associated #0: 25 --> en:drug cross-reactivity
    n1=en:allergy to caffeine | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=25
  127. en:erythrodermia --- r_associated #0: 25 --> en:drug cross-reactivity
    n1=en:erythrodermia | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=25
  128. en:reaction to drug excipients --- r_associated #0: 25 --> en:drug cross-reactivity
    n1=en:reaction to drug excipients | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=25
  129. en:reaction to food additive --- r_associated #0: 25 --> en:drug cross-reactivity
    n1=en:reaction to food additive | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=25
  130. en:solvent sensitivity --- r_associated #0: 25 --> en:drug cross-reactivity
    n1=en:solvent sensitivity | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=25
  131. en:virologic failure --- r_associated #0: 25 --> en:drug cross-reactivity
    n1=en:virologic failure | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=25
  132. allergie digestive --- r_associated #0: 24 --> en:drug cross-reactivity
    n1=allergie digestive | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=24
  133. en:allergy to fermented products --- r_associated #0: 24 --> en:drug cross-reactivity
    n1=en:allergy to fermented products | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=24
  134. en:cutaneous drug eruption --- r_associated #0: 24 --> en:drug cross-reactivity
    n1=en:cutaneous drug eruption | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=24
  135. en:enzyme induction --- r_associated #0: 24 --> en:drug cross-reactivity
    n1=en:enzyme induction | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=24
  136. intolérance médicamenteuse --- r_associated #0: 24 --> en:drug cross-reactivity
    n1=intolérance médicamenteuse | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=24
  137. Besredka (méthode de) --- r_associated #0: 23 --> en:drug cross-reactivity
    n1=Besredka (méthode de) | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=23
  138. en:scalded skin syndrome --- r_associated #0: 23 --> en:drug cross-reactivity
    n1=en:scalded skin syndrome | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=23
  139. en:red man syndrome --- r_associated #0: 22 --> en:drug cross-reactivity
    n1=en:red man syndrome | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=22
  140. en:smoke sensitivity --- r_associated #0: 22 --> en:drug cross-reactivity
    n1=en:smoke sensitivity | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=22
  141. allergies alimentaires --- r_associated #0: 21 --> en:drug cross-reactivity
    n1=allergies alimentaires | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=21
  142. effet indésirable --- r_associated #0: 21 --> en:drug cross-reactivity
    n1=effet indésirable | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=21
  143. en:medicinal allergy --- r_associated #0: 21 --> en:drug cross-reactivity
    n1=en:medicinal allergy | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=21
  144. en:oral allergy syndrome --- r_associated #0: 21 --> en:drug cross-reactivity
    n1=en:oral allergy syndrome | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=21
  145. Érythrodermie --- r_associated #0: 21 --> en:drug cross-reactivity
    n1=Érythrodermie | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=21
  146. Toxidermie --- r_associated #0: 20 --> en:drug cross-reactivity
    n1=Toxidermie | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=20
  147. Allergies alimentaires --- r_associated #0: 15 --> en:drug cross-reactivity
    n1=Allergies alimentaires | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=15
  148. effet de souffle (lésion par) --- r_associated #0: 15 --> en:drug cross-reactivity
    n1=effet de souffle (lésion par) | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=15
  149. Événement indésirable --- r_associated #0: 15 --> en:drug cross-reactivity
    n1=Événement indésirable | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=15
  150. Effet indésirable --- r_associated #0: 10 --> en:drug cross-reactivity
    n1=Effet indésirable | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=10
  151. en:digestive allergy --- r_associated #0: 10 --> en:drug cross-reactivity
    n1=en:digestive allergy | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=10
  152. en:lesion by blast effect --- r_associated #0: 10 --> en:drug cross-reactivity
    n1=en:lesion by blast effect | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=10
  153. en:undesirable event --- r_associated #0: 10 --> en:drug cross-reactivity
    n1=en:undesirable event | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=10
  154. oesophagite (classification de Savary et Miller) --- r_associated #0: 10 --> en:drug cross-reactivity
    n1=oesophagite (classification de Savary et Miller) | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=10
  155. red man syndrome --- r_associated #0: 10 --> en:drug cross-reactivity
    n1=red man syndrome | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=10
  156. effet Hamburger --- r_associated #0: 5 --> en:drug cross-reactivity
    n1=effet Hamburger | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=5
  157. effet indésirable d'un dispositif médical --- r_associated #0: 5 --> en:drug cross-reactivity
    n1=effet indésirable d'un dispositif médical | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=5
  158. syndrome de la peau ébouillantée --- r_associated #0: 5 --> en:drug cross-reactivity
    n1=syndrome de la peau ébouillantée | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=5
  159. évacuation(clichéen) --- r_associated #0: 5 --> en:drug cross-reactivity
    n1=évacuation(clichéen) | n2=en:drug cross-reactivity | rel=r_associated | relid=0 | w=5
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr